Hide metadata

dc.contributor.authorZhao, Xi
dc.contributor.authorRødland, Einar A
dc.contributor.authorSørlie, Therese
dc.contributor.authorVollan, Hans K M
dc.contributor.authorRussnes, Hege G
dc.contributor.authorKristensen, Vessela N
dc.contributor.authorLingjærde, Ole C
dc.contributor.authorBørresen-Dale, Anne-Lise
dc.date.accessioned2015-10-20T12:45:21Z
dc.date.available2015-10-20T12:45:21Z
dc.date.issued2014
dc.identifier.citationBMC Cancer. 2014 Mar 19;14(1):211
dc.identifier.urihttp://hdl.handle.net/10852/47286
dc.language.isoeng
dc.rightsZhao et al.; licensee BioMed Central Ltd.
dc.rightsAttribution 2.0 Generic
dc.rights.urihttp://creativecommons.org/licenses/by/2.0/
dc.titleSystematic assessment of prognostic gene signatures for breast cancer shows distinct influence of time and ER status
dc.typeJournal article
dc.date.updated2015-10-20T12:45:22Z
dc.creator.authorZhao, Xi
dc.creator.authorRødland, Einar A
dc.creator.authorSørlie, Therese
dc.creator.authorVollan, Hans K M
dc.creator.authorRussnes, Hege G
dc.creator.authorKristensen, Vessela N
dc.creator.authorLingjærde, Ole C
dc.creator.authorBørresen-Dale, Anne-Lise
dc.identifier.doihttp://dx.doi.org/10.1186/1471-2407-14-211
dc.identifier.urnURN:NBN:no-51391
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/47286/1/12885_2013_Article_4445.pdf
dc.type.versionPublishedVersion
cristin.articleid211


Files in this item

Appears in the following Collection

Hide metadata

Attribution 2.0 Generic
This item's license is: Attribution 2.0 Generic